Sharemaestro company-news research for Alumis Inc (ALMS), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NASDAQ
United States
Measured evidence
Company news sentiment
ALMS news sentiment
Alumis Inc
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone60Neutral is 50
Constructive news tone
53/100 evidence confidence
100% direct company focus
2 current stories across 2 publishers
Current company news
Positive news being faded
Constructive news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 2 publishers.
Latest source headline 4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026 finance.yahoo.com · 11 Aug 2026 13:44What supports the read
2 current stories are mapped specifically to ALMS.
Cross-story agreement is 95/100, indicating a comparatively coherent tape.
What tempers the read
Only 2 publishers currently contribute to the measured read.
Constructive headlines are not being rewarded by price, which raises a rejection flag.
60/100
Weighted toneConstructive news tone
53/100
Evidence confidencebuilding confidence
100%/100
Company focus2 direct stories
95/100
Evidence agreement5/100 dispersion
News history
Tone and story flow over 21 days
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth21
1.7 effective storiesSource breadth40
2 independent publishersDirect relevance100
company-specific evidence shareFreshness71
recency-weighted evidenceAgreement95
cross-story consistencySource independence41
lower publisher concentrationPrice context
Sentiment against the 26-week price path
Constructive headlines are not being rewarded by price, which raises a rejection flag.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
Sentiment confirms active trendPositive but stretched
News subjects
What is shaping the score
Earnings761 stories · 50%
Market update661 stories · 50%
Source mix
Where the evidence comes from
finance.yahoo.com761 stories · 50%
seekingalpha.com661 stories · 50%
Recurring subjects
Subjects appearing most often
Valuation1Psoriasis1Pharmaceuticals1Pharma1Momentum1Healthcare1Fourth Quarter1Fda Approval1Clinical Trials1Biotech1
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#176Tone
finance.yahoo.comDirect company coverage
4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026
The National Psoriasis Foundation recognizes August as Psoriasis Awareness Month, an annual initiative aimed at raising awareness, educating the public and supporting efforts to improve the lives of people affected by psoriasis and psoriatic arthritis. The focus is particularly relevant given the scale of the disease. More than eight million people in the United States live with psoriasis and nearly one-third of them may develop psoriatic arthritis. The opportunity for innovative psoriasis therapies extends beyond simply treating symptoms. The market is increasingly shifting toward targeted dr
BiologicsClinical TrialsFda ApprovalFourth QuarterPharmaPsoriasis
- Published
- 11 Aug 2026 13:44
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#266Tone
seekingalpha.comDirect company coverage
High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
[Heart Health Concept] Eoneren/E+ via Getty Images Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price velocity against fundamental underlying valuations. Analysts warn that chasing recent momentum can leave market participants overexposed to highly priced assets, prompting a rush toward selective screens that highlight cheap high flyers within the biotechnology, pharmaceuticals, medical equipment, and managed care sectors. Below is a list of the top 10 healthcare st
BiotechHealthcareMomentumPharmaceuticalsValuation
- Published
- 10 Aug 2026 12:49
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.